Patent Application
Utility
App. No. 14/467,741
· Confirmation No. 3224
Pharmaceutical Formulations Useful for Inhibiting Acid Secretion and Methods for Making and Using Them
Applicant:
Santarus, Inc.
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2018-10-03 | ABN |
Abandonment | 2 | View | |
| 2018-09-21 | XT/ |
Extension of Time | 2 | View | |
| 2018-09-21 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2018-09-21 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2018-03-22 | CTNF |
Non-Final Rejection | 16 | View | |
| 2018-03-22 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2018-03-22 | SRFW |
Search information including classification, databases and other search related notes | 2 | View | |
| 2018-02-27 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2018-02-27 | RCEX |
Request for Continued Examination (RCE) | 2 | View | |
| 2018-02-27 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2018-02-27 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2018-02-08 | ANE.I |
Amendment After Final or under 37CFR 1.312, initialed by the examiner. | 1 | View | |
| 2018-02-08 | CTAV |
Advisory Action (PTOL-303) | 3 | View | |
| 2018-01-31 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2018-01-31 | AMSB |
Amendment Submitted/Entered with Filing of Continued Prosecution Application (CPA)/Request for Continued Examination(RCE) | 1 | View | |
| 2018-01-31 | CLM |
Claims | 5 | View | |
| 2018-01-31 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2018-01-31 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2017-10-31 | CTFR |
Final Rejection | 16 | View | |
| 2017-10-31 | SRFW |
Search information including classification, databases and other search related notes | 2 | View | |
| 2017-10-31 | SRNT |
Examiner's search strategy and results | 2 | View | |
| 2017-07-24 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | 1 | View | |
| 2017-07-24 | CLM |
Claims | 5 | View | |
| 2017-07-24 | REM |
Applicant Arguments/Remarks Made in an Amendment | 3 | View | |
| 2017-07-24 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2017-07-24 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2017-07-24 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2017-01-23 | CTNF |
Non-Final Rejection | 13 | View | |
| 2017-01-23 | 892 |
List of references cited by examiner | 1 | View | |
| 2017-01-23 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2017-01-23 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2016-12-19 | A.NE |
Response After Final Action | 1 | View | |
| 2016-12-19 | SPEC |
Specification | 1 | View | |
| 2016-12-19 | CLM |
Claims | 5 | View | |
| 2016-12-19 | REM |
Applicant Arguments/Remarks Made in an Amendment | 5 | View | |
| 2016-12-19 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2016-12-19 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2016-11-04 | CTFR |
Final Rejection | 8 | View | |
| 2016-11-04 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2016-11-04 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2016-07-26 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | 1 | View | |
| 2016-07-26 | CLM |
Claims | 5 | View | |
| 2016-07-26 | REM |
Applicant Arguments/Remarks Made in an Amendment | 4 | View | |
| 2016-07-26 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2016-07-26 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2016-07-26 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2016-01-26 | CTNF |
Non-Final Rejection | 17 | View | |
| 2016-01-26 | 892 |
List of references cited by examiner | 1 | View | |
| 2016-01-26 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2016-01-26 | BIB |
Bibliographic Data Sheet | 1 | View | |
| 2016-01-26 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2015-02-12 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2014-11-06 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2014-11-06 | M327 |
Miscellaneous Communication to Applicant - No Action Count | 1 | View | |
| 2014-11-06 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2014-11-04 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 2 | View | |
| 2014-11-04 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2014-11-04 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2014-11-04 | DRW |
Drawings-only black and white line drawings | 13 | View | |
| 2014-09-04 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2014-09-04 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2014-09-04 | NT.CR.APP.PA |
Notice to File Corrected Application Papers | 2 | View | |
| 2014-08-25 | ADS |
Application Data Sheet | 8 | View | |
| 2014-08-25 | SPEC |
Specification | 116 | View | |
| 2014-08-25 | CLM |
Claims | 4 | View | |
| 2014-08-25 | ABST |
Abstract | 1 | View | |
| 2014-08-25 | DRW |
Drawings-only black and white line drawings | 24 | View | |
| 2014-08-25 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2014-08-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2014-08-25 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2014-08-25 | WFEE |
Fee Worksheet (SB06) | 1 | View |
Inventors
Attorneys & Agents of Record
Classification
USPC
514/338
A61K33/00
A61K9/0056
A61K9/0095
A61K9/2018
A61K9/2031
A61K9/2054
A61K9/2072
A61K9/48
A61K9/4858
A61K9/4866
A61K31/4439
A61K33/08
Prosecution
- Examiner
- POLANSKY, GREGG
- Art Unit
- 1621
- Customer No.
- 120260
- Docket No.
- 20215.0037.CNUS01
- Confirmation No.
- 3224
Publication
- Pub. No.
- US20150044303A1
- Pub. Date
- 2015-02-12
Parent
is a Continuation of
→
App. 11/287,888
· US 8,815,916
Filed 2005-11-28
· Patented Case
Parent
is a Continuation of
→
App. 11/138,763
· US 8,906,940
Filed 2005-05-25
· Patented Case
Parent
Claims priority from a provisional application
→
App. 60/574,646
Filed 2004-05-25
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 60/574,663
Filed 2004-05-25
· Provisional Application Expired
Child
is a Continuation of
→
App. 16/138,859
Filed 2018-09-21
· Abandoned -- Failure to Respond to an Office Action
Child
is a Continuation of
→
App. 17/489,939
Filed 2021-09-30
· Abandoned -- Failure to Respond to an Office Action
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, LTD.,
SALIX PHARMACEUTICALS, INC.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS IRELAND LIMITED
RELEASE OF SECURITY INTEREST
Recorded 2025-11-20
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH US, LLC,
SOLTA MEDICAL, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.
RELEASE OF SECURITY INTEREST
Recorded 2025-11-20
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
from
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH US, LLC,
MEDICIS PHARMACEUTICAL CORPORATION,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.
SECURITY INTEREST
Recorded 2019-03-11
from
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS IRELAND LIMITED,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED
SECURITY INTEREST
Recorded 2018-02-26
from
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS IRELAND LIMITED,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED
SECURITY INTEREST
Recorded 2018-02-26
from
GLYCYX PHARMACEUTICALS, LTD.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.
SECURITY AGREEMENT
Recorded 2015-04-02
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 14/467,741
- Filed
- 2014-08-25
- Pub. No.
- US20150044303A1
- Examiner
- POLANSKY, GREGG
- Art Unit
- 1621
External Links